Literature DB >> 21085006

Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States.

Suthat Liangpunsakul1.   

Abstract

BACKGROUND AND AIMS: Alcoholic hepatitis (AH) is the most florid manifestation of alcoholic liver disease. In this study, we examined the clinical characteristics and risk factors associated with mortality in hospitalized AH patients in the United States using the 2007 Nationwide inpatient sample of the Healthcare Cost and Utilization Project.
METHODS: Patients who were hospitalized with the primary diagnosis of AH in the United States in 2007 were identified using International Classification of Diseases-9 code. We further characterized these subjects based on associated symptoms (such as ascites, hepatic encephalopathy, and coagulopathy), complications during hospitalization (such as sepsis, pneumonia, spontaneous bacterial peritonitis, and acute renal failure), and categories pertaining to hospital characteristics, such as teaching status. The predictors of mortality were calculated using logistic regression analyses.
RESULTS: There were 8,043,415 in-patient admissions, of which 56,809 (0.71%) were hospitalized with the primary diagnosis of AH. The mean age was 53.2 years, and 27% were female. The average length of stay was 6.5±7.7 days and 3,881 subjects (6.8%) died during hospitalization. Medicare and Medicaid were the main primary expected payer sources (51.8%) with the average total charges during hospital stay of $37,769. In the multivariate analyses, older age, presence of sepsis, spontaneous bacterial peritonitis, pneumonia, urinary tract infection, acute renal failure, hepatic encephalopathy, and coagulopathy were independently associated with in-patient mortality.
CONCLUSIONS: In-hospital mortality rate for AH remains high, especially in those with infectious complications, hepatic encephalopathy, coagulopathy, and acute renal failure. Our analysis documented significant healthcare cost and utilization among hospitalized AH patients.

Entities:  

Mesh:

Year:  2011        PMID: 21085006      PMCID: PMC3135756          DOI: 10.1097/MCG.0b013e3181fdef1d

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

Review 1.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

2.  Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.

Authors:  E H Forrest; C D J Evans; S Stewart; M Phillips; Y H Oo; N C McAvoy; N C Fisher; S Singhal; A Brind; G Haydon; J O'Grady; C P Day; P C Hayes; L S Murray; A J Morris
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

3.  Corticosteroid therapy of alcoholic hepatitis.

Authors:  W C Maddrey; J K Boitnott; M S Bedine; F L Weber; E Mezey; R I White
Journal:  Gastroenterology       Date:  1978-08       Impact factor: 22.682

4.  MELD accurately predicts mortality in patients with alcoholic hepatitis.

Authors:  Winston Dunn; Laith H Jamil; Larry S Brown; Russell H Wiesner; W Ray Kim; K V Narayanan Menon; Michael Malinchoc; Patrick S Kamath; Vijay Shah
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

5.  Alcoholic liver disease-related mortality in the United States: 1980-2003.

Authors:  Helga Paula; Sumeet K Asrani; Nicholas C Boetticher; Rachel Pedersen; Vijay H Shah; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

6.  Teaching hospital status and operative mortality in the United States: tipping point in the volume-outcome relationship following colon resections?

Authors:  Awori J Hayanga; Debraj Mukherjee; David Chang; Heather Kaiser; Timothy Lee; Susan Gearhart; Nita Ahuja; Julie Freischlag
Journal:  Arch Surg       Date:  2010-04

7.  Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.

Authors:  E Christensen; P Schlichting; L Fauerholdt; C Gluud; P K Andersen; E Juhl; H Poulsen; N Tygstrup
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

8.  The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study.

Authors:  Geoffrey C Nguyen; Adriano J Correia; Paul J Thuluvath
Journal:  Dis Colon Rectum       Date:  2009-08       Impact factor: 4.585

9.  Direct medical costs of acute pancreatitis hospitalizations in the United States.

Authors:  Peter J Fagenholz; Carlos Fernández-del Castillo; N Stuart Harris; Andrea J Pelletier; Carlos A Camargo
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

10.  Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.

Authors:  Nobuyuki Toshikuni; Akiyoshi Izumi; Ken Nishino; Nobu Inada; Ritsuko Sakanoue; Ryumei Yamato; Mitsuhiko Suehiro; Miwa Kawanaka; Gotaro Yamada
Journal:  J Gastroenterol Hepatol       Date:  2009-04-06       Impact factor: 4.029

View more
  48 in total

1.  Current Management and Future Treatment of Alcoholic Hepatitis.

Authors:  Mack C Mitchell; Thomas Kerr; H Franklin Herlong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

2.  A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.

Authors:  Mauricio Garcia-Saenz-de-Sicilia; Chitharanjan Duvoor; Jose Altamirano; Roberta Chavez-Araujo; Veronica Prado; Ana de Lourdes Candolo-Martinelli; Patricia Holanda-Almeida; Bernardo Becerra-Martins-de-Oliveira; Simony Fernandez-de-Almeida; Ramón Bataller; Juan Caballeria; Andres Duarte-Rojo
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 3.  Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.

Authors:  Basile Njei; Albert Do; Thomas R McCarty; Brett E Fortune
Journal:  J Clin Gastroenterol       Date:  2016 Nov/Dec       Impact factor: 3.062

Review 4.  Alcoholic hepatitis and HCV interactions in the modulation of liver disease.

Authors:  C S Punzalan; T N Bukong; G Szabo
Journal:  J Viral Hepat       Date:  2015-03-06       Impact factor: 3.728

Review 5.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

6.  Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.

Authors:  Raul Lazaro; Raymond Wu; Sunyoung Lee; Nian-Ling Zhu; Chia-Lin Chen; Samuel W French; Jun Xu; Keigo Machida; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

7.  Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Authors:  Srinivasan Dasarathy; Mack C Mitchell; Bruce Barton; Craig J McClain; Gyongyi Szabo; Laura E Nagy; Svetlana Radaeva; Arthur J McCullough
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

8.  Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis.

Authors:  Paul J Thuluvath; Eric Ahn; Geoffrey C Nguyen
Journal:  Can J Gastroenterol       Date:  2013-09-13       Impact factor: 3.522

9.  Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Authors:  Adeyinka C Adejumo; George Cholankeril; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; Waldo C Concepcion; Donghee Kim; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2019-08-01       Impact factor: 3.199

Review 10.  Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.